封面
市場調查報告書
商品編碼
2077575

整形外科再生醫學市場:按類型、應用和地區分類

Orthopedic Regenerative Medicine Market, By Type, By Application, By Region

出版日期: | 出版商: Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到2026年,整形外科再生醫學市場規模將達到129.5億美元,到2033年將達到267.2億美元。預計從2026年到2033年,該市場將以10.9%的複合年成長率成長。

報告範圍 報告詳情
基準年: 2025 2026年市場規模: 129.5億美元
歷史數據時期: 2020-2024 預測期: 2026-2033
2026年至2033年預測期間的複合年成長率: 10.90% 2033年市場規模預測: 267.2億美元

整形外科再生醫學是一種生物來源(天然)物質開發的治療方法,整形外科專家可將其用於以下目的:它有助於緩解某些整形外科疾病(例如早期骨關節炎)引起的疼痛和其他症狀,並延緩手術需求。在再生整形外科療法中,提取並製備人體內自然產生的治療因子,然後將其注射到需要治療的部位。此過程不使用藥物或手術。骨科生技藥品不僅可用於治療某些關節炎等退化性疾病,還可用於治療運動傷害和創傷。透過再生醫學,有些患者可能完全避免整形外科手術。再生整形外科治療可以減輕肌肉骨骼疼痛和不適,並可能促進肌腱、韌帶、骨骼、肌肉、半月軟骨、軟骨和其他肌肉骨骼組織損傷等整形外科疾病的癒合。事實上,人體許多部位的自身修復能力相對較低。再生醫學的理念就是更好地促進這些組織的癒合。

市場動態

預計在預測期內,市場主要參與者推出新產品的增加將推動全球整形外科再生醫學市場的成長。例如,2020年6月,致力於開發下一代差異化產品以改善手術患者治療效果的商業化再生醫學公司Aziyo Biologics, Inc.宣布推出其最新的OsteGro系列產品「OsteGro V」。該產品是一種含有活細胞的骨基質,其中包含小梁骨顆粒以及脫礦皮質骨顆粒和纖維,以改善產品的使用性能。本產品採用Aziyo Biologics, Inc.的獨家流程進行最佳化,以保護和保存生物來源的骨細胞。

本研究的主要特點:

  • 該研究揭示了各個細分市場的潛在成長機會,並說明了該市場中一系列有吸引力的投資提案。
  • 此外,本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
  • 本研究根據以下參數介紹了全球整形外科再生醫學市場主要參與者的概況:公司概況、產品系列、主要亮點、財務表現和策略。
  • 本研究涵蓋的主要公司包括 Anika Therapeutics, Inc.、Arthrex, Inc.、Baxter International, Inc.、CONMED Corporation、Johnson & Johnson、Medtronic, Plc、Smith & Nephew plc、Orthofix、Stryker Corporation、Zimmer Holdings, Inc.、Aziyo Biologics、Orthoenerative Technologies Inc., Regssign。
  • 本報告提供的見解將有助於各公司的行銷負責人和經營團隊就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
  • 全球整形外科再生醫學市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等行業相關人員相關者。
  • 相關人員可以透過利用分析全球整形外科再生醫學市場中使用的各種策略矩陣來簡化決策過程。

目錄

第1章:研究目標與前提條件

  • 分析目的
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告說明
    • 市場定義和範圍
  • 執行摘要
  • 一致性機會圖(COM)

第3章:市場動態、監管與趨勢分析

  • 市場動態
    • 促進因素
    • 抑制因子
    • 市場機遇
  • 影響分析
  • 近期產品發布
  • 流行病學
  • 併購和合作
  • 監管趨勢
  • PEST分析

第4章 全球整形外科再生醫學市場:依類型分類,2021-2033年

  • 幹細胞
  • 生物材料
  • 組織工程

第5章 全球整形外科再生醫學市場:依應用領域分類,2021-2033年

  • 骨骼和關節疾病
  • 類風濕性關節炎
  • 韌帶損傷
  • 黏液囊炎
  • 骨質疏鬆症
  • 其他

第6章 全球整形外科再生醫學市場:依地區分類,2021-2033年

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 法國
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • ASEAN
    • 澳洲
    • 韓國
    • 其他亞太國家
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲國家
  • 中東
    • GCC
    • 以色列
    • 其他中東國家
  • 非洲
    • 北非
    • 中非
    • 南非

第7章 競爭情勢

  • 公司簡介
    • Anika Therapeutics, Inc
    • Arthrex, Inc.
    • Baxter International, Inc.
    • CONMED Corporation
    • Johnson & Johnson
    • Medtronic, Plc
    • Smith & Nephew plc
    • Orthofix
    • Stryker Corporation
    • Zimmer Holdings, Inc.
    • Aziyo Biologics
    • Ortho Regenerative Technologies Inc.
    • OssDsign

第8章

  • 參考
  • 調查方法
簡介目錄
Product Code: CMI4841

Orthopedic Regenerative Medicine Market is estimated to be valued at USD 12.95 Bn in 2026 and is expected to reach USD 26.72 Bn by 2033, growing at a compound annual growth rate (CAGR) of 10.9% from 2026 to 2033.

Report Coverage Report Details
Base Year: 2025 Market Size in 2026: USD 12.95 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2026 To 2033
Forecast Period 2026 to 2033 CAGR: 10.90% 2033 Value Projection: USD 26.72 Bn

Orthopedic regenerative medicine are therapies developed from biologic (natural) substances that can be used by orthopaedic specialists to: Help relieve pain and other symptoms of certain orthopaedic conditions, such as early osteoarthritis, which may help delay the need for surgery. With regenerative orthopedic therapy, healing elements that the body naturally produces are extracted, prepared, and then injected into the areas of the body that need healing, all without drugs or surgery. Orthobiologics can be used to treat degenerative conditions such as certain forms of arthritis, as well as sports injuries and traumas. Regenerative medicine may help some patients avoid orthopedic surgery completely. Regenerative orthopedics may improve pain and discomfort of the musculoskeletal system and enhance the healing of orthopedic conditions, such as injuries of a tendon, ligament, bone, muscle, spinal disc, meniscus of the knee, cartilage or other musculoskeletal tissue. Most of these parts of the body have a relatively poor ability to heal on their own. The idea behind regenerative medicine is to help these tissues heal better.

Market Dynamics

Increasing product launches by the key players in the market are expected to drive the growth of the global orthopedic regenerative medicine market over the forecast period. For instance, in June 2020, Aziyo Biologics, Inc., a commercial-stage regenerative medicine company creating the next generation of differentiated products to improve outcomes in patients undergoing surgery, announced the launch of its newest OsteGro family product, OsteGro V, a viable cell bone matrix containing cancellous bone particles as well as demineralized cortical bone particles and fibers to enhance product handling. The product is optimized to protect and preserve native bone cells through Aziyo Biologics, Inc.'s proprietary process.

Key features of the study:

  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global orthopedic regenerative medicine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Te key companies covered as a part of this study include Anika Therapeutics, Inc, Arthrex, Inc., Baxter International, Inc., CONMED Corporation, Johnson & Johnson, Medtronic, Plc, Smith & Nephew plc, Orthofix, Stryker Corporation, Zimmer Holdings, Inc., Aziyo Biologics, and Ortho Regenerative Technologies Inc., OssDsign
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • Global orthopedic regenerative medicine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global orthopedic regenerative medicine market

Global Orthopedic Regenerative Medicine Market Detailed Segmentation:

  • By Type (Revenue, USD Bn, 2021 - 2033)
  • Stem Cell
  • Biomaterial
  • Tissue Engineering
  • By Application (Revenue, USD Bn, 2021 - 2033)
  • Osteoarticular Diseases
  • Rheumatoid Arthritis
  • Ligament Injuries
  • Burisitis
  • Osteoporosis
  • Others
  • Regional Insights (Revenue, USD Bn, 2021 - 2033)
  • North America
    • U.S.
    • Canada
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
  • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Company Profiles
  • Anika Therapeutics, Inc
  • Arthrex, Inc.
  • Baxter International, Inc.
  • CONMED Corporation
  • Johnson & Johnson
  • Medtronic, Plc
  • Smith & Nephew plc
  • Orthofix
  • Stryker Corporation
  • Zimmer Holdings, Inc.
  • Aziyo Biologics
  • Ortho Regenerative Technologies Inc.
  • OssDsign.

Table of Contents

1. Research Objective and Assumption

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Application
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Recent Product Launches
  • Epidemiology
  • Merger, Acquisition, and Collaborations
  • Regulatory Scenario
  • Key Developments
  • PEST Analysis

4. Global Orthopedic Regenerative Medicine Market, By Type, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Stem Cell
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends
  • Biomaterial
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends
  • Tissue Engineering
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends

5. Global Orthopedic Regenerative Medicine Market, By Application, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • Osteoarticular Diseases
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends
  • Rheumatoid Arthritis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends
  • Ligament Injuries
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends
  • Burisitis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends
  • Osteoporosis
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (US$ Bn)
    • Segment Trends

6. Global Orthopedic Regenerative Medicine Market, By Region, 2021 - 2033, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2026 and 2033 (%)
    • Y-o-Y Growth Analysis, 2022-2033
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • U.S.
      • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Bn)
      • GCC
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Bn)
      • North Africa
      • Central Africa
      • South Africa

7. Competitive Landscape

  • Company Profiles
    • Anika Therapeutics, Inc
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Arthrex, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Baxter International, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • CONMED Corporation
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Johnson & Johnson
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Medtronic, Plc
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Smith & Nephew plc
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Orthofix
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Stryker Corporation
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Zimmer Holdings, Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Aziyo Biologics
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • Ortho Regenerative Technologies Inc.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies
    • OssDsign.
      • Company Overview
      • Product Portfolio
      • Key Highlights
      • Financial Overview
      • Strategies

8. Section

  • References
  • Research Methodology
  • About us and Sales Contact